Disc Medicine

IPO

Harnessing Breakthrough Science to Advance Hematology Care

Disc Medicine was founded in 2021, is headquartered in Watertown, United States, lists 51–200 employees, and has $222.5M in recorded funding across 4 rounds.

Employees
51–200
Founded
2021
Business Model
B2B
Total Funding
$222.5M
Last Round
$20.0M Series DFeb 2026
Rounds
4
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.

About

Disc Medicine is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for hematologic diseases. The company applies new insights in heme biosynthesis and iron metabolism to develop first-in-class therapies, including bitopertin for erythropoietic protoporphyria and DISC-0974 for myelofibrosis-associated anemia. Disc Medicine is listed on Nasdaq under the ticker IRON.

Summary

Disc Medicine is a Biotech company based in Watertown, United States, founded in 2021. It lists 51–200 employees. It has raised $222.5M in total across 4 rounds, most recently a $20.0M Series D round in Feb 2026. Investors include Bain Capital Life Sciences, OrbiMed and Atlas Venture.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series DSeries DFeb 2026
$20.0M

Sign up to see all 4 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Disc Medicine on Indexed.vc
<a href="https://indexed.vc/companies/disc-medicine"><img src="https://indexed.vc/api/badge/company/disc-medicine" alt="Disc Medicine on Indexed.vc" width="260" height="76" /></a>